BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 22939952)

  • 21. Tissue microarray analysis of 560 patients with colorectal adenocarcinoma: high expression of HuR predicts poor survival.
    Yoo PS; Sullivan CA; Kiang S; Gao W; Uchio EM; Chung GG; Cha CH
    Ann Surg Oncol; 2009 Jan; 16(1):200-7. PubMed ID: 19009247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activated leukocyte cell adhesion molecule (CD166)--its prognostic power for colorectal cancer patients.
    Tachezy M; Zander H; Gebauer F; Marx A; Kaifi JT; Izbicki JR; Bockhorn M
    J Surg Res; 2012 Sep; 177(1):e15-20. PubMed ID: 22482754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of CD44 expression in colorectal carcinomas.
    Sökmen S; Lebe B; Sarioglu S; Füzün M; Terzi C; Küpelioglu A; Ellidokuz H
    Anticancer Res; 2001; 21(6A):4121-6. PubMed ID: 11911305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of CXCL12 expression in patients with colorectal carcinoma.
    Akishima-Fukasawa Y; Nakanishi Y; Ino Y; Moriya Y; Kanai Y; Hirohashi S
    Am J Clin Pathol; 2009 Aug; 132(2):202-10; quiz 307. PubMed ID: 19605814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HMGA2 is associated with invasiveness but not a suitable marker for the detection of circulating tumor cells in breast cancer.
    Fabjani G; Tong D; Wolf A; Roka S; Leodolter S; Hoecker P; Fischer MB; Jakesz R; Zeillinger R
    Oncol Rep; 2005 Sep; 14(3):737-41. PubMed ID: 16077985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic impact of fascin-1 expression is more significant in advanced colorectal cancer.
    Oh SY; Kim YB; Suh KW; Paek OJ; Moon HY
    J Surg Res; 2012 Jan; 172(1):102-8. PubMed ID: 20851411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer.
    Takeuchi T; Hisanaga M; Nagao M; Ikeda N; Fujii H; Koyama F; Mukogawa T; Matsumoto H; Kondo S; Takahashi C; Noda M; Nakajima Y
    Clin Cancer Res; 2004 Aug; 10(16):5572-9. PubMed ID: 15328199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential expression of alpha-methylacyl-coenzyme A racemase in colorectal carcinoma bears clinical and pathologic significance.
    Lin A; Weiser MR; Klimstra DS; Paty PB; Tang LH; Al-Ahmadie H; Hoo Park S; Guillem JG; Temple L; Wong WD; Gerald WL; Shia J
    Hum Pathol; 2007 Jun; 38(6):850-6. PubMed ID: 17442371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stromal myofibroblasts predict disease recurrence for colorectal cancer.
    Tsujino T; Seshimo I; Yamamoto H; Ngan CY; Ezumi K; Takemasa I; Ikeda M; Sekimoto M; Matsuura N; Monden M
    Clin Cancer Res; 2007 Apr; 13(7):2082-90. PubMed ID: 17404090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SMAD4 as a prognostic marker in colorectal cancer.
    Alazzouzi H; Alhopuro P; Salovaara R; Sammalkorpi H; Järvinen H; Mecklin JP; Hemminki A; Schwartz S; Aaltonen LA; Arango D
    Clin Cancer Res; 2005 Apr; 11(7):2606-11. PubMed ID: 15814640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical significance of BMP7 in human colorectal cancer.
    Motoyama K; Tanaka F; Kosaka Y; Mimori K; Uetake H; Inoue H; Sugihara K; Mori M
    Ann Surg Oncol; 2008 May; 15(5):1530-7. PubMed ID: 18259822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of gene signatures for invasive colorectal tumor cells.
    Wiese AH; Auer J; Lassmann S; Nährig J; Rosenberg R; Höfler H; Rüger R; Werner M
    Cancer Detect Prev; 2007; 31(4):282-95. PubMed ID: 17936523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extrahepatic synthesis of coagulation factor VII by colorectal cancer cells promotes tumor invasion and metastasis.
    Tang JQ; Fan Q; Wu WH; Jia ZC; Li H; Yang YM; Liu YC; Wan YL
    Chin Med J (Engl); 2010 Dec; 123(24):3559-65. PubMed ID: 22166631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematic assessment of protein phenotypes characterizing high-grade tumour budding in mismatch repair-proficient colorectal cancer.
    Karamitopoulou E; Lugli A; Panayiotides I; Karakitsos P; Peros G; Rallis G; Patsouris ES; Terracciano L; Zlobec I
    Histopathology; 2010 Aug; 57(2):233-43. PubMed ID: 20716165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HMGI(Y) gene expression in colorectal cancer: comparison with some histological typing, grading, and clinical staging.
    Balcerczak M; Pasz-Walczak G; Balcerczak E; Wojtylak M; Kordek R; Mirowski M
    Pathol Res Pract; 2003; 199(10):641-6. PubMed ID: 14666966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of high-risk stage II colorectal tumors by combined analysis of the NDRG1 gene expression and the depth of tumor invasion.
    Strzelczyk B; Szulc A; Rzepko R; Kitowska A; Skokowski J; Szutowicz A; Pawelczyk T
    Ann Surg Oncol; 2009 May; 16(5):1287-94. PubMed ID: 19259744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of p16 in lymph node metastases of adjuvantly treated stage III colorectal cancer patients identifies poor prognostic subgroups: a retrospective analysis of biomarkers in matched primary tumor and lymph node metastases.
    Karamitopoulou E; Zlobec I; Koumarianou A; Patsouris ES; Peros G; Lugli A
    Cancer; 2010 Oct; 116(19):4474-86. PubMed ID: 20572035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methylation status of T-lymphoma invasion and metastasis 1 promoter and its overexpression in colorectal cancer.
    Jin H; Li T; Ding Y; Deng Y; Zhang W; Yang H; Zhou J; Liu C; Lin J; Ding Y
    Hum Pathol; 2011 Apr; 42(4):541-51. PubMed ID: 21237486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis.
    Hu WG; Li JW; Feng B; Beveridge M; Yue F; Lu AG; Ma JJ; Wang ML; Guo Y; Jin XL; Zheng MH
    Eur Surg Res; 2007; 39(4):229-38. PubMed ID: 17446709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lactate dehydrogenase 5 expression in operable colorectal cancer: strong association with survival and activated vascular endothelial growth factor pathway--a report of the Tumour Angiogenesis Research Group.
    Koukourakis MI; Giatromanolaki A; Sivridis E; Gatter KC; Harris AL;
    J Clin Oncol; 2006 Sep; 24(26):4301-8. PubMed ID: 16896001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.